Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3mvl | 38P | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.588 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.572 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.572 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.569 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.559 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.554 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.553 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.545 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.542 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.539 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.531 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.531 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.529 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.528 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.526 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.524 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.515 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.515 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.513 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.513 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.512 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.512 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.512 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.503 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.502 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.502 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.501 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.501 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.501 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.501 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.498 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.495 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.494 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.493 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.492 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.488 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.485 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.485 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.485 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.483 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.482 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.479 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.478 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.478 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.477 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.477 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.476 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.476 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.475 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.474 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.474 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.473 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.471 | |
| 1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.469 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.469 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.468 | |
| 3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
| 4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.466 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.463 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.463 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.463 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.461 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 3iqe | F42 | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.461 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.461 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.461 | |
| 4j54 | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.461 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.461 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.460 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.460 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.459 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
| 4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.459 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.458 | |
| 3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
| 1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
| 2c3i | IYZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.457 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
| 4ye3 | G04 | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.457 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.456 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.456 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.456 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.455 | |
| 4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.454 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 2wec | PP5 | Penicillopepsin-1 | 3.4.23.20 | 0.454 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.454 | |
| 3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
| 2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.453 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.453 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.453 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.453 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.453 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.453 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.452 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.452 | |
| 3nbw | TR4 | Ketohexokinase | / | 0.452 | |
| 3zux | TCH | Transporter | / | 0.452 | |
| 4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.452 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
| 4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.452 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.450 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
| 4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.450 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.450 | |
| 1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.449 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.449 | |
| 3orm | AGS | Serine/threonine protein kinase | / | 0.449 | |
| 3q92 | XNB | Ketohexokinase | / | 0.449 | |
| 3sa6 | F71 | Protease | / | 0.449 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.449 | |
| 1j39 | UPG | DNA beta-glucosyltransferase | / | 0.448 | |
| 1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.448 | |
| 3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.448 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.448 | |
| 4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.448 | |
| 4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.447 | |
| 1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.447 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2baq | PQB | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.446 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
| 4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.446 | |
| 4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.446 | |
| 4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
| 5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
| 1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.445 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.445 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.445 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 4oth | DRN | Serine/threonine-protein kinase N1 | / | 0.445 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.445 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.444 | |
| 2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.444 | |
| 3djk | G55 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.444 | |
| 3upj | U03 | Gag-Pol polyprotein | / | 0.444 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.444 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.444 | |
| 4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.444 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.444 | |
| 1z1r | HBH | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 2nu9 | COA | Succinate--CoA ligase [ADP-forming] subunit alpha | 6.2.1.5 | 0.443 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.443 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
| 3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.443 | |
| 3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.443 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.443 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.443 | |
| 4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.443 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.443 | |
| 4iak | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.443 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.442 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.442 | |
| 2w4i | VGA | Glutamate racemase | / | 0.442 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 4q73 | FAD | Bifunctional protein PutA | / | 0.442 | |
| 1ppj | SMA | Cytochrome b | / | 0.441 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.441 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
| 3a2o | KNJ | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.441 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.441 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 4n6z | 2HW | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 4q71 | FAD | Bifunctional protein PutA | / | 0.441 | |
| 4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.440 | |
| 1hii | C20 | Gag-Pol polyprotein | / | 0.440 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.440 | |
| 1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2bpz | 3IN | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 2ieo | 017 | Protease | / | 0.440 | |
| 3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.440 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.440 | |
| 4o76 | 1M3 | Bromodomain-containing protein 4 | / | 0.440 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.440 |